Save your place

Sign in to WhoBought

Please try again later.

IDEAYA Biosciences, Inc. (IDYA) institutional ownership

Latest close $36.77 Jul 27, 2026
Market cap$2.2B 52-week range SectorHealthcare
Funds holding · Q1 2026
229
reported IDYA position changes
Top owners · Q1 2026
No disclosed owners are available.
Institutional activity · Q1 2026
Activity unavailable N/A
122 buyers · 107 sellers

IDEAYA Biosciences, Inc. (IDYA) price and institutional activity

Dates

Q1 2026

$0 bought by 122 investors
Morgan StanleyGeode +120 more
$0 sold by 107 investors
Point72 Asset Management, L.P.Deerfield Management Company, L.P. +105 more
Bought Sold Totals per quarter; hover a bar for the names.

IDEAYA Biosciences, Inc. (IDYA) institutional activity · 229

Investor Type Est. change Change Δ Own Date
Point72 Asset Management, L.P. · Reduced
Change −1.5M Δ Own −82.2% Date Q1 2026
Point72 Asset Management, L.P. Reduced· Q1 2026 −1.5M −82.2% Q1 2026
Deerfield Management Company, L.P. · Reduced
Change −623K Date Q1 2026
Deerfield Management Company, L.P. Reduced· Q1 2026 −623K Q1 2026
Morgan Stanley · Added
Change +608K Date Q1 2026
Morgan Stanley Added· Q1 2026 +608K Q1 2026
Geode · Added
Change +427K Date Q1 2026
Geode Added· Q1 2026 +427K Q1 2026
Federated Hermes, Inc. · Reduced
Change −409K Date Q1 2026
Federated Hermes, Inc. Reduced· Q1 2026 −409K Q1 2026
BNP Paribas Asset Management Holding S.A. · Added
Change +403K Date Q1 2026
BNP Paribas Asset Management Holding S.A. Added· Q1 2026 +403K Q1 2026
Dimensional · Added
Change +395K Date Q1 2026
Dimensional Added· Q1 2026 +395K Q1 2026
Balyasny Asset Management L.P. · Reduced
Change −388K Date Q1 2026
Balyasny Asset Management L.P. Reduced· Q1 2026 −388K Q1 2026
State Street · Reduced
Change −353K Date Q1 2026
State Street Reduced· Q1 2026 −353K Q1 2026
Baker Bros. Advisors LP · Added
Change +328K Date Q1 2026
Baker Bros. Advisors LP Added· Q1 2026 +328K Q1 2026
Logos Global Management LP · Added
Change +325K Date Q1 2026
Logos Global Management LP Added· Q1 2026 +325K Q1 2026
UBS Group AG · Reduced
Change −323K Date Q1 2026
UBS Group AG Reduced· Q1 2026 −323K Q1 2026
Eventide Asset Management, LLC · Exited
Change −284K Δ Own −100.0% Date Q1 2026
Eventide Asset Management, LLC Exited· Q1 2026 −284K −100.0% Q1 2026
Citadel Advisors LLC Reduced· Q1 2026 −280K −29.2% Q1 2026
Jennison Associates LLC · New
Change +256K Date Q1 2026
Jennison Associates LLC New· Q1 2026 +256K Q1 2026
Data through Q1 2026 · filed Jun 4, 2026
15 of 229

Famous investor activity in IDEAYA Biosciences, Inc. (IDYA)

IDEAYA Biosciences, Inc. (IDYA) insider trading

Company insiders, action and economics first; trade and filed dates last.
Dates
Insider Title Type Price Qty Value Owned ΔOwn Trade date Filed date
Ruiz Briseno Andres · Officer Sell −$382K
Price $40.01 Qty −10K Owned 26K ΔOwn −26.5% Trade date Jul 7, 2026 Filed date Jul 9, 2026
Ruiz Briseno Andres Officer Sell $40.01 −10K −$382K 26K −26.5% Jul 7, 2026 Jul 9, 2026
Ruiz Briseno Andres · Officer 2 operations 0
Price $12.86 Owned 19K Trade date Jul 7, 2026 Filed date Jul 9, 2026
Ruiz Briseno Andres Officer 2 operations $12.86 0 19K Jul 7, 2026 Jul 9, 2026
Yarno Wendy L. · Director Grant (A) 20K
Owned 20K Trade date Jun 16, 2026 Filed date Jun 18, 2026
Yarno Wendy L. Director Grant (A) 20K 20K Jun 16, 2026 Jun 18, 2026
Stein Jeffrey · Director Grant (A) 20K
Owned 20K Trade date Jun 16, 2026 Filed date Jun 18, 2026
Stein Jeffrey Director Grant (A) 20K 20K Jun 16, 2026 Jun 18, 2026
Rosen Terry J. · Director Grant (A) 20K
Owned 20K Trade date Jun 16, 2026 Filed date Jun 18, 2026
Rosen Terry J. Director Grant (A) 20K 20K Jun 16, 2026 Jun 18, 2026
Morrison Scott W. · Director Grant (A) 20K
Owned 20K Trade date Jun 16, 2026 Filed date Jun 18, 2026
Morrison Scott W. Director Grant (A) 20K 20K Jun 16, 2026 Jun 18, 2026
Mackey Catherine J. · Director Grant (A) 20K
Owned 20K Trade date Jun 16, 2026 Filed date Jun 18, 2026
Mackey Catherine J. Director Grant (A) 20K 20K Jun 16, 2026 Jun 18, 2026
Hampton Malcolm Garret · Director Grant (A) 20K
Owned 20K Trade date Jun 16, 2026 Filed date Jun 18, 2026
Hampton Malcolm Garret Director Grant (A) 20K 20K Jun 16, 2026 Jun 18, 2026
Stein Jeffrey · Director Buy +$1.6M
Price $32.96 Qty +50K Owned 54K Trade date Mar 2, 2026 Filed date Mar 2, 2026
Stein Jeffrey Director Buy $32.96 +50K +$1.6M 54K Mar 2, 2026 Mar 2, 2026
Bleharski Joshua · Officer Grant (A) 170K
Owned 170K Trade date Jan 30, 2026 Filed date Feb 2, 2026
Bleharski Joshua Officer Grant (A) 170K 170K Jan 30, 2026 Feb 2, 2026
White Michael Anthony · Officer Grant (A) 190K
Owned 190K Trade date Jan 30, 2026 Filed date Feb 2, 2026
White Michael Anthony Officer Grant (A) 190K 190K Jan 30, 2026 Feb 2, 2026
Beaupre Darrin · Officer Grant (A) 175K
Owned 175K Trade date Jan 30, 2026 Filed date Feb 2, 2026
Beaupre Darrin Officer Grant (A) 175K 175K Jan 30, 2026 Feb 2, 2026
Dorman Stuart · Officer Grant (A) 155K
Owned 155K Trade date Jan 30, 2026 Filed date Feb 2, 2026
Dorman Stuart Officer Grant (A) 155K 155K Jan 30, 2026 Feb 2, 2026
Hata Yujiro S. · Director, Officer Grant (A) 600K
Owned 600K Trade date Jan 30, 2026 Filed date Feb 2, 2026
Hata Yujiro S. Director, Officer Grant (A) 600K 600K Jan 30, 2026 Feb 2, 2026
Snyder Douglas B. · Officer Grant (A) 130K
Owned 130K Trade date Jan 30, 2026 Filed date Feb 2, 2026
Snyder Douglas B. Officer Grant (A) 130K 130K Jan 30, 2026 Feb 2, 2026
15 of 18
15 of 18 Sign in to continue to older insider transactions.

IDEAYA Biosciences, Inc. (IDYA) activist and large shareholders

Dates
Owner/Filer identity Shares reported % of shares outstanding Filing date
FMR LLC 12.6M
% of shares outstanding 15.0% Filing date Nov 12, 2024
FMR LLC 12.6M 15.0% Nov 12, 2024
BlackRock Inc. 5.4M
% of shares outstanding 8.4% Filing date Jan 25, 2024
BlackRock Inc. 5.4M 8.4% Jan 25, 2024
Janus Henderson Group PLC 7.3M
% of shares outstanding 8.3% Filing date May 15, 2026
Janus Henderson Group PLC 7.3M 8.3% May 15, 2026
Federated Hermes, Inc. 3.9M
% of shares outstanding 6.0% Filing date Jan 18, 2024
Federated Hermes, Inc. 3.9M 6.0% Jan 18, 2024
Vanguard Group Inc 3.5M
% of shares outstanding 5.4% Filing date Feb 13, 2024
Vanguard Group Inc 3.5M 5.4% Feb 13, 2024
T. Rowe Price Associates 4.0M
% of shares outstanding 4.8% Filing date Nov 14, 2024
T. Rowe Price Associates 4.0M 4.8% Nov 14, 2024
Boxer Capital, LLC 2.2M
% of shares outstanding 4.6% Filing date Feb 14, 2023
Boxer Capital, LLC 2.2M 4.6% Feb 14, 2023
Adage Capital Partners Gp, L.L.C. 2.9M
% of shares outstanding 4.5% Filing date Feb 7, 2024
Adage Capital Partners Gp, L.L.C. 2.9M 4.5% Feb 7, 2024
8 of 14

IDEAYA Biosciences, Inc. (IDYA) ownership FAQ

Who owns IDYA?

229 reporting institutions disclosed IDYA position changes in the Q1 2026 snapshot.

How is institutional activity calculated?

For each manager, WhoBought compares accepted consecutive 13F share counts. Share change is current shares minus prior shares. Estimated dollar change is that signed share change multiplied by the split-adjusted quarter-mean close. The activity table on this page uses Q1 2026.

What are activist and large shareholder filings?

An investor crossing 5% of a share class generally files Schedule 13D for activist intent or Schedule 13G for a passive position. The technical form names appear here rather than in the activity rows.

Where does this data come from?

Ownership and institutional activity come from SEC Form 13F filings. Insider activity comes from SEC Form 4, and large-shareholder activity from SEC Schedules 13D and 13G. FMP supplies price data only. Company logos use the local verified Parqet cache with one shared fallback.

Why are ownership reports delayed?

Form 13F is a quarterly disclosure and is normally filed after the quarter ends. Every ownership and activity value therefore names its represented period; it is not presented as a live position.

How are missing table values shown?

A muted dash marks a missing table value. It means the filing omitted the value, comparable data is unavailable, or no prior position exists for comparison.